Day: January 4, 2021
Kalamazoo, Michigan, Jan. 04, 2021 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that it will host a conference call on Wednesday, January 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company’s operating results for the quarter ended December 31, 2020 and provide an operational update. Final operating results for the quarter ended December 31, 2020 will be released at 4:05 p.m. that day.To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 5283279 to the operator.A simultaneous webcast of the call will be accessible via the Company’s website at www.stryker.com. The call will be archived on the Investor Relations page of this site.A recording of the call will also be available from 8:00 p.m., Eastern Time, on Wednesday,...
Genmab Announces Phase 3 Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
Written by Customer Service on . Posted in Public Companies.
Media ReleaseInitiation of a global phase 3 trial for tisotumab vedotin versus investigator’s choice chemotherapy in recurrent or metastatic cervical cancerGenmab A/S (Nasdaq: GMAB) announced today the initiation of innovaTV 301 trial, a global phase 3 study to evaluate the efficacy of tisotumab vedotin compared to chemotherapy in patients with recurrent or metastatic cervical cancer who have received one or two prior lines of systemic therapy. The innovaTV 301 trial is a global, randomized phase 3 trial in which tisotumab vedotin will be compared with physician’s choice single agent chemotherapy.“Currently, there is no established standard of care for women with recurrent or metastatic cervical cancer, who have disease progression after first or second line of therapy. There is a need for a novel, safe and effective treatment option...
Forwardly, Inc. Provides Shareholder Update
Written by Customer Service on . Posted in Public Companies.
Boulder City, NV, Jan. 04, 2021 (GLOBE NEWSWIRE) — George Sharp, President and CEO of Forwardly, Inc. (OTCMKT: FORW), is pleased to announce that the company’s common shares have been deemed eligible by the Depository Trust Corporation (“DTC”) for electronic transfer through the Deposit/Withdrawal at Custodian (“DWAC”) platform.DWAC eligibility makes Forwardly much more attractive to future investors in the company and its projects, as shares which are issued in certificate form are not accepted for deposit by most brokerage firmsMr. Sharp also announced that the shareholder video conference call, previously scheduled for January 12, 2021 has been rescheduled to February 16, 2021 to coincide with the release of the company’s annual financial report. Further details regarding the conference call will be released in a future press...
DATA443 ENTERS ANOTHER RECORD YEAR – RENEWS LEADING INSURANCE COMPANY IN MULTI–YEAR DEAL
Written by Customer Service on . Posted in Public Companies.
Hosted Secure Archiving and Privacy Platform Leading Multi-Year, Six-Figure DealRESEARCH TRIANGLE PARK, NC, Jan. 04, 2021 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (OTCPK: ATDS), the leading data security and privacy software company for ALL THINGS DATA SECURITY™, is pleased to announce its latest customer win for its leading Global Privacy Manager™ suite of products anchored by its award winning ArcMail™ Secure Data Archiving hosted platform.The multi-year subscription-based agreement is another six figure deal for the growing SaaS-based offering that Data443 offers.Jason Remillard, CEO of Data443 commented, “Even in one of the most challenging years on record, both teams worked hard together to continue to bring the whole project together. An enormous amount of data is involved, which was greatly complicated by the events...
Liquidity contract half-yearly report as of Dec 31, 2020
Written by Customer Service on . Posted in Public Companies.
Half-yearly report relative to the liquidity contract entered into between NATIXIS and ODDO BHF SCA Under the liquidity contract relative to NATIXIS shares, entered into between NATIXIS and ODDO CORPORATE FINANCE, the following resources were listed on the liquidity account at December 31, 2020: 3,912,890 NATIXIS shares€ 8,807,250.61We remind you that on implementing the contract, the following resources were listed on the liquidity account:3,566,311 NATIXIS shares€ 5,313,783.30AttachmentNATIXIS liquidity contract half-yearly report 12-31, 2020
Contrat de liquidité bilan semestriel au 31/12/2020
Written by Customer Service on . Posted in Public Companies.
Bilan semestriel du contrat de liquidité NATIXIS contracté avec ODDO BHF SCAAu titre du contrat de liquidité confié par la société NATIXIS à ODDO BHF SCA, à la date du 31 décembre 2020, les moyens suivants figuraient au compte de liquidité : 3 912 890 titres8 807 250,61 euros en espèces Il est rappelé que lors de la mise en place du contrat, les moyens suivants figuraient au compte de liquidité :3 566 311 titres5 313 583,30 € en espèces Pièce jointeBilan semestriel NATIXIS CL 31-12-2020
Plumas Bancorp Announces the Retirement of Past President and Board Member William E. Elliott
Written by Customer Service on . Posted in Public Companies.
QUINCY, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) — Plumas Bancorp (Nasdaq:PLBC), the parent company of Plumas Bank, announced the recent retirement of board director, William E. Elliott, after 33 years of service. Mr. Elliott’s retirement, effective December 31, 2020, was required by the age-based retirement policy in the Company’s Corporate Governance Guidelines. Elliott joined the bank in 1987 as president, chief executive officer, and director and he helped lead the company through numerous years of growth. Elliott retired as president and chief executive officer in 2005 but he continued to serve on the board for an additional 15 years.Chairman of the Board, Daniel E. West, remarked, “We are extremely grateful to Bill for his significant contributions during his 18-year tenure as president and 33-year tenure as a director. Bill...
ADLPartner : Déclaration des transactions sur actions propres réalisées du 28 au 31 décembre 2020
Written by Customer Service on . Posted in Public Companies.
ADLPartnerSociété anonyme à directoire et conseil de surveillance au capital de 6 478 836 euros3, avenue de Chartres 60500 – CHANTILLY393 376 801 R.C.S. CompiègneDéclaration des transactions sur actions propres réalisées du 28 au 31 décembre 2020Présentation agrégée par jour et par marchéDétail transaction par transactionRelations Investisseurs & Informations financièresTel : +33 1 41 58 72 03 – Courriel : relations.investisseurs@adlpartner.frADLPartner est cotée sur Euronext Paris – Compartiment CCodes ISIN : FR0000062978-ALP – Bloomberg : ALP FP – Reuters : ALDP.PAwww.adlpartner.comPièce jointeADLPartner_rachats_actions_04012021
VERB Technology to Showcase Industry-Leading verbLIVE Livestream eCommerce and Webinar Platform at CES 2021
Written by Customer Service on . Posted in Public Companies.
NEWPORT BEACH, Calif. and SALT LAKE CITY, Jan. 04, 2021 (GLOBE NEWSWIRE) — VERB Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), a leader in interactive video-based sales enablement applications, including interactive livestream ecommerce, webinar, CRM and marketing applications for entrepreneurs and enterprises, today announced that it will be showcasing its industry-leading verbLIVE platform at CES 2021, the first all-virtual Consumer Electronics Show, on January 11-14, 2021. Rory J. Cutaia, VERB CEO, will highlight the Company’s sales enablement technology innovations and virtually connect with customers, media, and other thought leaders.verbLIVE, the Company’s livestream ecommerce and webinar application, is a powerful and easy-to-use tool that enables sales people to increase client...
Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
WALTHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the 39th Annual J.P. Morgan Healthcare conference being held January 11-14. Tony J. Hunt, President and Chief Executive Officer, will make a formal presentation on Wednesday, January 13, at 9:10 a.m. EST.A live webcast of the presentation will be accessible through the Investor Relations section of the Company’s website, and will be available for replay for a limited period of time following the conference event.About Repligen CorporationRepligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of...